Psychiatry and Neurology, Neurology · Evansville, IN
NPI
1043451727
Since 2009
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
600 Mary St
Evansville, IN, 47710
Phone (812) 450-7338
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
1,373 services
Medicare patients, 2024
546
Average age 74
Drug cost, 2024
$411K
431 prescriptions
Company payments, 2025
$1,159
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bhargav A Trivedi was code 99233 (hospital e&m - subsequent), 483 times for 278 patients. In total Bhargav A Trivedi billed 1,373 services in 20 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 483 | 278 | $86.11 | $42K |
| 99291 Critical Care E&M | Facility | 254 | 137 | $151.87 | $39K |
| 99223 Hospital E&M - Initial | Facility | 216 | 209 | $124.15 | $27K |
| 99214 Office E&M - Established | Facility | 143 | 79 | $68.33 | $9,772 |
| 95816 Neurologic | Facility | 80 | 80 | $40.30 | $3,224 |
| 99205 Office E&M - New | Facility | 36 | 36 | $119.78 | $4,312 |
| 99215 Office E&M - Established | Facility | 31 | 27 | $105.82 | $3,281 |
| 95819 Neurologic | Facility | 30 | 30 | $41.81 | $1,254 |
| 99232 Hospital E&M - Subsequent | Facility | 25 | 18 | $54.23 | $1,356 |
| 99204 Office E&M - New | Facility | 22 | 22 | $97.59 | $2,147 |
| 95822 Neurologic | Facility | 19 | 18 | $41.70 | $792 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $95.89 | $1,055 |
By year: 2022 $157K for 1,619 services; 2023 $113K for 1,156 services; 2024 $136K for 1,373 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bhargav A Trivedi prescribed most often to Medicare patients was Levetiracetam, with 66 prescriptions and refills. In total Bhargav A Trivedi wrote 431 Medicare prescriptions that cost $411K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 66 | 166 | 19 | $3,013 |
| Mycophenolate Mofetil Generic | 31 | 57 | Under 11 | $2,665 |
| Pyridostigmine Bromide Generic | 30 | 58 | Under 11 | $3,772 |
| Atorvastatin Calcium Generic | 24 | 52 | Under 11 | $98.08 |
| Pyridostigmine Bromide Er Pyridostigmine Bromide | 21 | 34 | Under 11 | $24K |
| Amlodipine Besylate Generic | 20 | 30 | Under 11 | $31.11 |
| Kesimpta Pen Ofatumumab | 20 | 26 | Under 11 | $234K |
| Lacosamide Generic | 16 | 20 | Under 11 | $3,819 |
| Clopidogrel Clopidogrel Bisulfate | 16 | 38 | Under 11 | $159 |
| Ropinirole Hcl Generic | 15 | 20 | Under 11 | $137 |
| Memantine Hcl Generic | 14 | 18 | Under 11 | $605 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 14 | 26 | Under 11 | $111 |
| Repatha Sureclick Evolocumab | 12 | 12 | Under 11 | $6,629 |
| Famotidine Generic | 11 | 21 | Under 11 | $68.56 |
Brand drugs: 62 claims; generic drugs: 369 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bhargav A Trivedi $1,159 ($1,159 in general payments such as food, travel and fees) from 12 companies. The largest payer was Vanda Pharmaceuticals Inc. with $241.
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. VNDA | 4 | $241 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $223 |
| Abbvie Inc. ABBV | 12 | $159 |
| Eisai Inc. 4523.T | 4 | $127 |
| Argenx US, Inc. ARGX | 6 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $106 |
| UCB, Inc. UCB.BR | 3 | $68.82 |
| Lilly USA, LLC LLY | 2 | $46.71 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $25.97 |
| Biogen, Inc. BIIB | 1 | $20.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.